INO

Inovio Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↑ 6/10
  • Value↓ 0/10
Inovio Pharmaceuticals sales and earnings growth
INO Growth
Good
  • Revenue Y/Y↓ -69.99%
  • EPS Y/Y↑ 54.18%
  • FCF Y/Y↑ 14.92%
Inovio Pharmaceuticals gross and profit margin trends
INO Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -130000.00%
  • ROIC 5Y↓ -294.30%
Inovio Pharmaceuticals net debt vs free cash flow
INO Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Inovio Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗